For the Inventor, By the Inventor

Enter assignee name

Pharmacia & Upjohn

Calculating rank

USPTO Granted Patents = 117

% Expired Patents = 15.4

CIPO Patents = 1

Forward Citations = 1,023

Loading Chart...

Loading Chart...

225 inventors (with patents filed for the assignee):

Mario Varasi (21 out of 72 patents)

Antonino Suarato (16 out of 55 patents)

Tiziano Bandiera (13 out of 43 patents)

4. Angelo Bedeschi (12 out of 37 patents)

5. Carmela Speciale (12 out of 13 patents)

6. Ilaria Candiani (11 out of 27 patents)

7. Michele Caruso (11 out of 39 patents)

8. Paolo Pevarello (10 out of 49 patents)

9. Dario Ballinari (10 out of 19 patents)

10. Jacqueline Lansen (9 out of 11 patents)

11. Walter Cabri (7 out of 74 patents)

12. Laura Capolongo (7 out of 12 patents)

13. Anna Luisa Colombo (7 out of 10 patents)

14. Franco Zarini (7 out of 22 patents)

15. Sergio Mantegani (6 out of 27 patents)

Core Competencies:

Alzheimer's Disease

Antitumor Agents

Integrin Antagonists

Camptothecin Derivatives

Oxazolidinones

Pyridopyrimidinones

Distamycin Derivatives

Matrix Metalloproteinase Inhibitors

5HT1A Ligands

Neuroprotective Agents

Synthetic Processes

Pharmaceutical Compositions

117 patents: Sort by Forward Citations

1. 7354943 - Statine derivatives for the treatment of Alzheimer's disease (2008-04-08),

2. 7317011 - Method of treating peripheral neuropathy (2008-01-08),

3. 7214715 - Compounds to treat Alzheimer's disease (2007-05-08),

4. 7087784 - Process to prepare oxazolidinones (2006-08-08),

5. 7037929 - 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents (2006-05-02),

6. 7037695 - Methods of assessing wolframin protein activity (2006-05-02),

7. 7019002 - Pyridopyrimidinones derivatives as telomerase inhibitors (2006-03-28),

8. 6964965 - Substituted pyrazine derivatives (2005-11-15),

9. 6878730 - Quaternary ammonium compounds (2005-04-12),

10. 6864290 - Statine derivatives for the treatment of Alzheimer's disease (2005-03-08),

11. 6863647 - 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents (2005-03-08),

12. 6841557 - Compounds for the treatment of addictive disorders (2005-01-11),

13. 6831081 - 4-Oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents (2004-12-14),

14. 6794385 - Benzoxazine derivatives useful as integrin receptor antagonists (2004-09-21),

15. 6753316 - Acryloyl derivatives analogous to distamycin, process for preparing them, and their use as antitumor agents (2004-06-22),

Company Overview

Pharmacia & Upjohn, headquartered in Milan, Italy, specializes in the development and manufacturing of innovative antitumor agents. The organization focuses on advanced therapeutic solutions targeting various conditions, including Alzheimer's disease and cancer. Its core technology areas encompass integrin antagonists, camptothecin derivatives, and matrix metalloproteinase inhibitors, among others. By leveraging cutting-edge research, Pharmacia & Upjohn aims to address significant medical challenges and improve patient outcomes in oncology and related fields.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

117 Patents

#23 in Milan

#77 in Italy

#6,803 in the World

Pharmacia & Upjohn

Forward Citations = 1,023

225 inventors:

Mario Varasi (21 out of 72 patents)

Antonino Suarato (16 out of 55 patents)

Tiziano Bandiera (13 out of 43 patents)

4. Angelo Bedeschi (12 out of 37 patents)

5. Carmela Speciale (12 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pharmacia & Upjohn. Retrieved from https://idiyas.com/company/pharmacia-and-upjohn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…